Hosted by the European Molecular Biology Organization (EMBO)

Blood cancers are still challenging to treat, despite diverse therapeutic options. Cancer underlies evolutionary principles with single cells and clones being selectable entities. They evolve over time, which has relevance to treatment and provides a potential time window for interceptive strategies. The aim of this EMBO workshop is to accelerate our understanding of tumor evolution, its mutability, plasticity, and adaptation at the single-cell level in order to promote novel prevention and precision medicine approaches for blood cancer. The scientific program covers both basic research and clinical science and has been set up with a focus on interdisciplinary approaches and modern technologies ranging from single-cell-omics, artificial intelligence and computational modeling to realistic 3D-culture-systems and in vivo-models of blood cancer. This EMBO workshop brings together young scientists and clinicians with leading experts and provides an ideal environment for interdisciplinary networking among participants, exchange of knowledge and scientific ideas and will foster exciting new collaborations.

More information and to register (registration closes 15 February 2024)